A new ‘Taiwan-Merck Biopharma R&D and Training Collaboration Program is set to launch in May
Taiwan News
Date: 2018/03/26
By: Duncan DeAeth, Taiwan News, Staff Writer
TAIPEI (Taiwan News) – Taiwan’s Industrial Technology Research institute (ITRI), one of
ITRI and Merck sign MoU on March 26 (Image Courtesy of ITRI)
the world’s leading research centers for smart technologies, signed an MoU with the American chemical company Merck, on Monday, March 26 in Taipei.
The agreement announces the establishment of the “Taiwan-Merck Biopharma R&D and Training Collaboration” set to launch in May, at the Guangfu Innovation Campus in Hsinchu, Taiwan, according to an official press release.
As Taiwan moves forward with its ambitious “5 +2” industrial innovation program, Merck and ITRI’s new partnership expects to be a leader in the rapidly developing biopharma sector, which is anticipated to value US$278 billion by the year 2020. [FULL STORY]